National Guideline for Management of Non-Communicable Diseases (NCDs)

Objectives

Provide a national clinical framework for preventing, detecting, treating and monitoring non-communicable diseases in Rwanda, responding to the growing burden of chronic conditions while improving access to care and quality of life. The framework spans cardiovascular disease, chronic respiratory disease, diabetes, chronic kidney disease, cancer, palliative care and community health assessment.[1][2]

• Strengthen prevention, diagnosis, treatment, monitoring and referral for complex chronic conditions across health-system levels.[1][3]
• Manage cardiovascular disease through assessment and severity classification of heart failure, hypertension, rheumatic heart disease, cardiomyopathies, postoperative cardiac conditions and anticoagulation needs.[4][5][6][7][8][9]
• Improve blood-pressure control and reduce associated complications, including heart failure, chronic kidney disease and stroke, through staged treatment, lifestyle modification and urgent management of hypertensive emergencies.[10][11]
• Diagnose and manage asthma, chronic obstructive pulmonary disease and bronchiectasis, while excluding alternative causes of cough, wheeze and dyspnoea and escalating severe attacks promptly.[12][13][14]
• Establish diabetes type and glycaemic status, prevent acute complications, tailor therapy to clinical circumstances, and support lifelong insulin treatment, nutrition, physical activity, education and psychosocial support where required.[15][16][17]
• Detect chronic kidney disease early, address underlying risk factors and delay progression to end-stage disease through renal-function assessment, risk-factor management and specialist referral.[18][19][20]
• Reduce cancer morbidity through prevention, awareness, early detection, screening, diagnostic confirmation, referral, treatment and palliative care, with cervical and breast cancer identified as feasible screening priorities.[21][3][22]
• Prevent recurrent acute rheumatic fever, reduce rheumatic heart disease severity and deaths, and manage cardiac complications through treatment and long-term secondary prophylaxis.[7][23]
• Prevent and relieve suffering from life-threatening illness by addressing physical, psychological, social and spiritual needs, improving quality of life and providing palliative care alongside life-prolonging treatment.[24][25]

Implementation

Implement the framework through structured, disease-specific clinical pathways that organise initial and follow-up visits around history, vital signs, examination, laboratory or imaging review, clinical assessment and a management plan. Care is delivered through referral and escalation across community, health-centre, district-hospital, teaching-hospital and referral-hospital levels, supported by specialist review for complex cases.[2][26][15][3]

• Coordinate national implementation through the Ministry of Health, Rwanda Biomedical Center and the Non-Communicable Diseases Technical Working Group, drawing on national teaching hospitals, professional associations, international partners, civil society and disability organisations.[1][2]
• Apply guidance developed and validated by general practitioners and specialists with urban and rural experience and aligned with international standards.[1]
• Use clinical triage and referral pathways to identify emergencies and transfer patients requiring district-hospital, specialist or inpatient care, including severe heart failure, hypertensive emergency, respiratory distress, diabetic emergencies and serious palliative symptoms.[5][27][28][16][29]
• Match service functions to level of care: community health workers provide prevention, awareness, mobilisation, referral linkage and home-based palliative support; health centres provide screening, clinical assessment, selected treatment and referral; hospitals provide diagnostics, staging, specialist treatment, surgery, chemotherapy, coordination and cancer registration.[3]
• Support cardiac postoperative follow-up through trained doctors and nurses at teaching and district hospitals under cardiologist, National Nurse Coordinator and Non-Communicable Diseases Division or Cardiovascular Diseases Unit supervision; provide secondary prophylaxis and essential medicines at health centres.[30][31]
• Maintain continuity of rheumatic heart disease care through registration with local health authorities or the rheumatic heart disease programme, diagnosis alerts, regular medical and dental review, echocardiography and cardiology follow-up.[7][23]
• Develop a web-based national preoperative and postoperative cardiac follow-up database, supported by a rheumatic heart disease registry, mobile phones and email.[30][31]
• Use disease-specific monitoring schedules, including blood pressure, renal function, electrolytes, blood glucose, glycated haemoglobin, urine testing, echocardiography, imaging, international normalised ratio monitoring and clinical symptom review.[32][11][33][34][31]
• Provide self-management and patient education on medicine adherence, danger signs, diet, smoking and alcohol cessation, physical activity, inhaler technique, insulin adjustment, anticoagulation safety, symptom control and when to seek urgent care.[6][10][14][35][9][36]
• Deliver palliative care through a multidisciplinary, patient- and family-centred approach that includes symptom assessment, pain management, psychosocial and spiritual support, bereavement counselling where indicated, emergency referral and appropriate home care.[24][25][37]

Monitoring & Evaluation

Monitoring is principally clinical and condition-specific, using structured initial and follow-up assessments rather than a unified programme-wide performance framework. The available material does not define a comprehensive national indicator set, routine reporting schedule, surveillance architecture, evaluation methodology, audit process, or formal accountability system across non-communicable disease services.[1][3][38]

• Monitor cardiovascular care through vital signs, symptoms, laboratory results, imaging, New York Heart Association class, ejection fraction, volume status, renal function, treatment response, and referral thresholds.[5][39]
• Measure creatinine and potassium after heart-failure treatment changes, repeat echocardiography every three to six months after significant clinical change, and organise follow-up intervals according to stability, renal function, volume status, and medicine changes.[32][6]
• Monitor anticoagulation through international normalised ratio testing before treatment, every one to three days during dose establishment or adjustment, and monthly when stable, with more frequent checks following changes in diet, medicines, or disease status.[31][9]
• Use postoperative cardiac supervision, referral-hospital review, trained district-hospital teams, rheumatic heart disease registration, and a proposed web-based national database to support continuity of care.[30][31]
• Track hypertension through repeat blood-pressure measurement, treatment adherence, clinical findings, laboratory results, and stage-specific follow-up, including 30-minute blood-pressure checks during hypertensive emergencies pending transfer.[40][27][41]
• Monitor childhood acute hypertension in a high-dependency setting through hourly blood-pressure assessment for 24 hours, fluid input and output, gradual blood-pressure reduction, and assessment for end-organ complications.[42][43]
• Maintain rheumatic fever and rheumatic heart disease continuity through local registration, alerts in medical files or computer systems where applicable, prophylaxis-adherence review, echocardiography, dental review, and cardiologist follow-up.[7][23]
• Review respiratory disease at follow-up to confirm asthma or chronic obstructive pulmonary disease severity, assess symptom control, adherence and inhaler technique, and determine whether treatment should be stepped up or down.[26][14][44]
• Monitor diabetes through fingerstick blood glucose at every visit, glycated haemoglobin at six-monthly intervals, weight and blood pressure at routine visits, and periodic creatinine, urine protein, retinal and foot assessments.[33][16][45]
• Monitor diabetic ketoacidosis intensively through vital signs, neurological status, fluid balance, cardiac activity, glucose, electrolytes, acid-base status, ketones and urine output; assess resolution using pH, bicarbonate, and anion-gap criteria.[46][47][18]
• Assess chronic kidney disease progression through serial estimated glomerular filtration rate, creatinine, urine protein, urea, haemoglobin and potassium testing, with accelerated progression defined by specified sustained declines in renal function.[34][21]
• Assign district hospitals cancer coordination, monitoring and evaluation, cancer registration, and research functions, while using screening, diagnostic confirmation, staging and referral to track progression through care. Quantitative cancer-service indicators and reporting schedules are not specified.[3][22]
• Use cervical-screening pathway results and one-year rescreening for women with human papillomavirus positivity as explicit follow-up mechanisms.[48]
• Monitor gestational trophoblastic disease through serial beta human chorionic gonadotropin testing, including monthly monitoring after molar-pregnancy treatment until three negative results and scheduled follow-up after chemotherapy.[49][50]
• Reassess palliative-care patients at follow-up for adherence, pain control, symptom burden, psychosocial and spiritual needs, and emergency signs; use the Rwanda Community Health Assessment Checklist to record structured community-level information.[25][36][38]

Costing & Financing

No explicit costs, budget allocations, financing sources, resource-mobilisation targets, funding gaps, or economic assumptions are specified in the available material.[1][3][51]

• Identify substantial resource requirements for clinical delivery, including diagnostic laboratories, imaging, echocardiography, electrocardiography, international normalised ratio testing equipment and strips, essential medicines, intravenous treatment, specialist review, referral transport, hospital admission, surgery, chemotherapy, radiotherapy and palliative-care medicines, but without associated prices or funding arrangements.[30][31][3][37]
• Require intensive-care inputs for diabetic ketoacidosis, including frequent laboratory monitoring, cardiac monitoring, intravenous fluids, insulin, potassium replacement, and experienced treatment centres, without a stated costing framework.[46][47][18]
• Require chronic kidney disease services to provide repeated laboratory testing, renal ultrasound where available, nephrology referral, medication management and palliative care according to disease stage, but without budget or financing detail.[34][20][21]
• Require cancer services across the health system, from community awareness and screening through imaging, biopsy, pathology, surgery, chemotherapy, radiotherapy, referral and palliative care, without stated allocations, funding sources or affordability assumptions.[3][22]
• Require continuity resources for rheumatic heart disease, including benzathine penicillin prophylaxis, registry systems, dental review, echocardiography and cardiology follow-up, but no associated costs are provided.[7][23]